G-protein-coupled receptor signaling through Gpr176, Gz, and RGS16 tunes time in the center of the circadian clock [Review

Endocrine Journal
Kaoru GotoHitoshi Okamura

Abstract

G-protein-coupled receptors (GPCRs) constitute an immensely important class of drug targets with diverse clinical applications. There are still more than 120 orphan GPCRs whose cognate ligands and physiological functions are not known. A set of circadian pacemaker neurons that governs daily rhythms in behavior and physiology resides in the suprachiasmatic nucleus (SCN) in the brain. Malfunction of the circadian clock has been linked to a multitude of diseases, such as sleeping disorders, obesity, diabetes, cardiovascular diseases, and cancer, which makes the clock an attractive target for drug development. Here, we review a recently identified role of Gpr176 in the SCN. Gpr176 is an SCN-enriched orphan GPCR that sets the pace of the circadian clock in the SCN. Even without known ligand, this orphan receptor has an agonist-independent basal activity to reduce cAMP signaling. A unique cAMP-repressing G-protein subclass Gz is required for the activity of Gpr176. We also provide an overview on the circadian regulation of G-protein signaling, with an emphasis on a role for the regulator of G-protein signaling 16 (RGS16). RGS16 is indispensable for the circadian regulation of cAMP in the SCN. Developing drugs that target the SCN rema...Continue Reading

References

Jan 17, 1992·Science·Y H WongH R Bourne
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M MatsuokaY Kaziro
May 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·H K FongM I Simon
Mar 14, 1995·Biochimica Et Biophysica Acta·S HataT Osumi
May 23, 2002·Cell·Satchidananda PandaJohn B Hogenesch
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Zdenka Travnickova-BendovaPaolo Sassone-Corsi
Apr 18, 2003·Current Biology : CB·Mitsugu SujinoShin-Ichi T Inouye
Apr 23, 2005·Science·Fred W TurekJoseph Bass
Nov 17, 2007·Pharmacology & Therapeutics·Geetanjali BansalZhihui Xie
Apr 19, 2008·Cold Spring Harbor Symposia on Quantitative Biology·H Okamura
May 20, 2008·Science·John S O'NeillMichael H Hastings
Jan 9, 2010·Annual Review of Pharmacology and Toxicology·Georgios K PaschosGarret A FitzGerald
Jun 12, 2012·The Journal of Comparative Neurology·Sungwon AnErik D Herzog
Sep 15, 2012·Biological & Pharmaceutical Bulletin·Masao Doi
Sep 19, 2015·PloS One·Adam L MartinRobert S Aronstam
Mar 12, 2016·Proceedings of the National Academy of Sciences of the United States of America·Nicola J SmyllieMichael H Hastings

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.